Tirzepatide (Mounjaro) is a weight loss drug that was approved by the National Institute for Health and Care and Excellence (NICE) in the UK on 23 December 2024.
We are anticipating guidance from NHS England which will help us implement our plans to prescribe this drug to people with the greatest clinical need in a safe and effective way, alongside a reduced-calorie diet, increased physical activity and psychological support.
Please click on the link below for more information: